QOL and Febrile Neutropenia: Japanese Phase 2 Trial of Docetaxel with/out Antiangiogenic Agent in 2nd Line NSCLC
JOURNAL OF THORACIC ONCOLOGY（2017）
关键词
Targeted therapy,antiangiogenesis,advanced NSCLC,Patient reported outcomes (PRO)
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要